Author

P. Rider

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Gutwillig· 2 shared D. Rasoulouniriana· 2 shared L. Farhat-Younis· 2 shared N. Santana-Magal· 2 shared Y. Carmi· 2 shared A. Ashkenazi· 1 shared A. Barzel· 1 shared A. Gleiberman· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Gutwillig

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity

Y. Carmi, L. Farhat-Younis, M. Na, A. Zarfin, N. Santana-Magal, A. Richter, A. Khateeb, A. Gutwillig, D. Rasoulouniriana, A. Gleiberman, L. Beck, T. Giger, A. Ashkenazi, A. Barzel, P. Rider

This study modifies myeloid cells to elicit tumor-specific cytotoxicity using chimeric receptors that signal through IgM and bind tumor antigens.

bioRxiv · Sep 30, 2023Immunology

A Herpes Simplex Virus Type-1-derived influenza vaccine induces balanced adaptive immune responses and protects mice from lethal influenza virus challenge.

P. Rider, H. Dulin, I. K. Uche, M. McGee, B. Breitenstein, G. S. Tan, W. Huang, K. Kousoulas, R. Hai

bioRxiv · Aug 5, 2021Microbiology

Transient cell-in-cell formation underlies tumor resistance to immunotherapy

A. Gutwillig, N. Santana-Magal, L. Farhat-Younis, D. Rasoulouniriana, A. Madi, C. Luxenburg, J. Cohen, K. Padmanabhan, N. Shomron, G. Shapira, M. Feinmesser, O. Zlotnik, R. Debets, N. E. Reticker-Flynn, P. Rider, Y. Carmi

This study identifies transient cell-in-cell formations as a mechanism enabling tumor resistance to immunotherapy, showing they protect tumor cells from immune and chemotherapy attacks.

bioRxiv · Sep 10, 2020 · PreprintImmunology